Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR5 | P35346 | 9/20 | 0.39 |
| ▸ | GJB2 | P29033 | 1/20 | 0.36 |
| ▸ | GJA1 | P17302 | 1/20 | 0.36 |
| ▸ | SSTR3 | P32745 | 4/20 | 0.35 |
| ▸ | SSTR2 | P30874 | 2/20 | 0.35 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.35 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.35 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.34 |
| ▸ | SLC5A1 | P13866 | 3/20 | 0.34 |
| ▸ | SLC5A2 | P31639 | 3/20 | 0.34 |
| ▸ | TACR1 | P25103 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14490088 | 0.92 | SLC6A2 (0.38) | SSTR5GJB2SSTR3SSTR2SSTR1 | |
| SCHEMBL14221752 | 0.91 | SSTR5 (0.39) | SSTR5GJB2GJA1SSTR3SSTR2 | |
| SCHEMBL14490089 | 0.90 | SSTR1 (0.40) | SSTR5GJB2GJA1SSTR3SSTR2 | |
| SCHEMBL13380946 | 0.90 | SSTR5 (0.42) | SSTR5GJB2GJA1SSTR3SSTR2 | |
| SCHEMBL13855505 | 0.85 | SSTR5 (0.37) | SSTR5SSTR3SSTR2SSTR1SSTR4 | |
| SCHEMBL6336303 | 0.84 | SSTR4 (0.39) | SSTR5GJB2GJA1SSTR3SSTR2 | |
| SCHEMBL3156185 | 0.83 | SSTR5 (0.46) | SSTR5SSTR3SSTR2SSTR1SSTR4 | |
| SCHEMBL13381041 | 0.83 | SSTR5 (0.46) | SSTR5SSTR3SSTR2SSTR1SSTR4 | |
| SCHEMBL7902126 | 0.83 | SSTR5 (0.46) | SSTR5SSTR3SSTR2SSTR1SSTR4 | |
| SCHEMBL7030616 | 0.83 | SSTR5 (0.33) | SSTR5GJB2GJA1SSTR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100081708-A1 | ANTICOAGULANT COMPOUNDS | ENDOTIS PHARMA (FR) | 2010-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100081708-A1 | ANTICOAGULANT COMPOUNDS | SERPINC1, F2, FUT5 | SSTR5 1014/4885GJB2 4413/4885GJA1 4395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.